Marianna (AnnaMaria) Anesti, PhD

Marianna (AnnaMaria) Anesti, PhD has a diverse and extensive work experience in the pharmaceutical and biotech industry. Marianna (AnnaMaria) currently serves as the Vice President of Corporate Strategy & Business Development at SIGA Technologies since 2019. Prior to this, they worked as a Director of Strategy & Consulting at Pfizer in 2018, where they focused on strategic planning and consulting.

Before joining Pfizer, Marianna spent a significant portion of their career at PwC, starting in 2011. During their time at PwC, they held various roles, including Director of Pharma Life Sciences R&D Management Consulting. In this position, they led large transformational engagements for biotech and pharma clients, communicated recommendations to senior leadership, facilitated decision-making, built client relationships, and conducted business development.

Marianna's work at PwC involved several projects, such as the development and execution of integrated strategies for virtual product development networks, the development of product and portfolio strategies, market assessments, optimization of clinical operations, development of disease state guidance, and assessment of regulatory guidelines. Marianna (AnnaMaria) also contributed to the development of commercialization strategies and launch plans for new products in major European countries.

Earlier in their career, Marianna worked at BioVex, a gene therapy company. Marianna (AnnaMaria) held the role of Director of Product & Business Development, where they were responsible for the strategy, business development, and commercialization of custom vectors for pharma clients. Marianna (AnnaMaria) also served as a Research Scientist, focusing on the development of the NeuroVex RNAi Platform and the application of RNAi to improve the OncoVEX-GMCSF cancer vaccine.

Overall, Marianna Anesti's work experience demonstrates their expertise in corporate strategy, business development, strategic planning, consulting, and gene therapy.

Marianna (AnnaMaria) Anesti, PhD has a strong educational background in the field of science and business. Marianna (AnnaMaria) holds a PhD in Immunology and Molecular Pathology from UCL. Additionally, they have an MBA in Business Administration from Hult International Business School. Prior to their MBA, they obtained an MSc in Molecular Medicine from UCL. Marianna (AnnaMaria) started their educational journey with a BSc in Medical Biochemistry from the University of Birmingham.